View Single Post
  #5  
Old Thu Jul 23, 2015, 08:15 AM
italianburrito italianburrito is offline
Member
 
Join Date: Apr 2015
Location: VB
Posts: 61
Quote:
Originally Posted by Neil Cuadra View Post
I posed your question to a transplant specialist, Dr. Sally Arai from the Stanford University Medical Center. She told me that Vidaza may be given to MDS patients after a reduced-intensity transplant, to lessen the chances of relapse. This matches what you heard.
Thank you so much for the info! I plan on contacting Dr. Arai and getting her take on everything. Any other exciting news? I know in oncology things are always changing and evloving. Thank you for being an advocate for us! You are heaven sent
__________________
Daughter of father diagnosed with MDS RAEB-II intermediate risk due to normal cytogenetics. Blasts at 13% peripheral blood at diagnosis with no cytopenias. 6 cycles on Vidaza then on to SCT at Duke. BMT from my brother and now showing signs of relapse. DLI in the works.
Reply With Quote